Medication info
Han In Memantine 10 mg (Memantine Hydrochloride)

Han In Memantine 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Han In Pharmaceutical Co., Ltd.
Appearance
Pale yellow to yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, (export 30 tablets (10 tablets/PTP X 3), 50 tablets (10 tablets/PTP X 5))
Approval status
Active

MFDS item code 201404518 · Approved 2014.09.30 · Insurance code 657202740

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (day 1~7) Administer 5mg once daily for 7 days. Week 2 (day 8~14) Administer 10mg once daily for 7 days. Week 3 (day 15~21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after administration, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Han In Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used in the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (day 1~7) Administer 5mg once daily for 7 days. Week 2 (day 8~14) Administer 10mg once daily for 7 days. Week 3 (day 15~21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after administration, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medicine should never be used by individuals who are allergic to its ingredients. It should also not be administered to patients with very poor liver function or severe renal impairment. Particular caution should be exercised when used by patients with epilepsy, those who have previously experienced seizures, and individuals with a high likelihood of developing epilepsy. Additionally, taking this drug with other drugs that have similar effects, such as amantadine, ketamine, or dextromethorphan, can increase central nervous system side effects, so concurrent use should be avoided. Changes in diet that may alter urine acidity or specific urinary tract infections should be carefully monitored during use. Caution is necessary for patients with recent history of myocardial infarction, heart failure, or uncontrolled hypertension, as the safety of this drug has not been adequately proven in these populations. When taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; if these symptoms arise, you should consult with healthcare professionals. Additionally, this drug can interact with various medications, so if you are taking other medicines, you must inform your doctor or pharmacist. Women who are pregnant or may become pregnant need to make careful judgments before using this drug, and it is advisable to discontinue breastfeeding while taking it. It is recommended not to use in children or adolescents under 18 years of age as safety and efficacy have not been established. In case of overdose, various symptoms such as confusion, drowsiness, dizziness, vomiting, and diarrhea may occur, and in such cases, appropriate treatment should be sought immediately at a medical facility. This medication may impair reaction time, requiring caution when driving or operating machinery. Lastly, this medication should be stored out of reach of children, and transferring it to another container is important for maintaining the quality of the drug.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 32 more
  • psychiatric reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • shortness of breath
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 to 30 degrees Celsius. This will help maintain the drug's effectiveness safely.

Appearance and packaging

Appearance

Pale yellow to yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, (export 30 tablets (10 tablets/PTP X 3), 50 tablets (10 tablets/PTP X 5))

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.